Trine Saugstrup

812 total citations · 1 hit paper
8 papers, 611 citations indexed

About

Trine Saugstrup is a scholar working on Hematology, Surgery and Molecular Biology. According to data from OpenAlex, Trine Saugstrup has authored 8 papers receiving a total of 611 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Hematology, 2 papers in Surgery and 1 paper in Molecular Biology. Recurrent topics in Trine Saugstrup's work include Hemophilia Treatment and Research (5 papers), Platelet Disorders and Treatments (4 papers) and Hemostasis and retained surgical items (2 papers). Trine Saugstrup is often cited by papers focused on Hemophilia Treatment and Research (5 papers), Platelet Disorders and Treatments (4 papers) and Hemostasis and retained surgical items (2 papers). Trine Saugstrup collaborates with scholars based in Denmark, United States and Germany. Trine Saugstrup's co-authors include Juris J. Meier, Ildiko Lingvay, Søren T. Hoff, Michael A. Nauck, Aslam Amod, Takashi Kadowaki, Richard E. Pratley, Karen Boje Pedersen, Dorthe Viuff and Mirella Ezban and has published in prestigious journals such as The Lancet, Blood and The Annals of Thoracic Surgery.

In The Last Decade

Trine Saugstrup

8 papers receiving 591 citations

Hit Papers

Oral semaglutide versus subcutaneous liraglutide and plac... 2019 2026 2021 2023 2019 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Trine Saugstrup Denmark 6 405 284 125 124 98 8 611
J Freiman United States 5 180 0.4× 95 0.3× 59 0.5× 30 0.2× 123 1.3× 6 360
Astrid Breitschaft Denmark 11 406 1.0× 191 0.7× 16 0.1× 165 1.3× 123 1.3× 17 542
Bryan Goldman Denmark 7 415 1.0× 203 0.7× 19 0.2× 208 1.7× 116 1.2× 11 514
Anne Hickman United States 13 201 0.5× 132 0.5× 18 0.1× 62 0.5× 94 1.0× 32 360
F. Pricolo Italy 9 267 0.7× 223 0.8× 22 0.2× 48 0.4× 82 0.8× 12 470
Domenica A. McCarthy Australia 8 130 0.3× 90 0.3× 42 0.3× 21 0.2× 84 0.9× 15 303
P Andréadis Greece 6 298 0.7× 154 0.5× 13 0.1× 64 0.5× 87 0.9× 14 402
Shinji Kamei Japan 11 191 0.5× 90 0.3× 23 0.2× 24 0.2× 105 1.1× 44 356
Elke Seewaldt-Becker Germany 7 972 2.4× 510 1.8× 17 0.1× 160 1.3× 588 6.0× 7 1.1k
Claire C. J. Dekkers Netherlands 9 599 1.5× 210 0.7× 15 0.1× 74 0.6× 319 3.3× 13 734

Countries citing papers authored by Trine Saugstrup

Since Specialization
Citations

This map shows the geographic impact of Trine Saugstrup's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Trine Saugstrup with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Trine Saugstrup more than expected).

Fields of papers citing papers by Trine Saugstrup

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Trine Saugstrup. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Trine Saugstrup. The network helps show where Trine Saugstrup may publish in the future.

Co-authorship network of co-authors of Trine Saugstrup

This figure shows the co-authorship network connecting the top 25 collaborators of Trine Saugstrup. A scholar is included among the top collaborators of Trine Saugstrup based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Trine Saugstrup. Trine Saugstrup is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Pratley, Richard E., Aslam Amod, Søren T. Hoff, et al.. (2019). Oral semaglutide versus subcutaneous liraglutide and placebo in type 2 diabetes (PIONEER 4): a randomised, double-blind, phase 3a trial. The Lancet. 394(10192). 39–50. 411 indexed citations breakdown →
2.
Aroda, Vanita R., Trine Saugstrup, John B. Buse, et al.. (2019). Incorporating and interpreting regulatory guidance on estimands in diabetes clinical trials: The PIONEER 1 randomized clinical trial as an example. Diabetes Obesity and Metabolism. 21(10). 2203–2210. 53 indexed citations
3.
Jiménez‐Yuste, Víctor, Sandra Lejniece, Robert Klamroth, et al.. (2014). The pharmacokinetics of a B‐domain truncated recombinant factor VIII, turoctocog alfa (NovoEight®), in patients with hemophilia A. Journal of Thrombosis and Haemostasis. 13(3). 370–379. 23 indexed citations
4.
Song, Howard K., Christian von Heymann, Christian M. Jespersen, et al.. (2014). Safe Application of a Restrictive Transfusion Protocol in Moderate-Risk Patients Undergoing Cardiac Operations. The Annals of Thoracic Surgery. 97(5). 1630–1635. 19 indexed citations
6.
Santagostino, Elena, Steven R. Lentz, Mudi Misgav, et al.. (2014). Safety and efficacy of turoctocog alfa (NovoEight®) during surgery in patients with haemophilia A: results from the multinational guardian clinical trials. Haemophilia. 21(1). 34–40. 39 indexed citations
7.
Jiménez‐Yuste, Víctor, Sandra Lejniece, Robert Klamroth, Trine Saugstrup, & Judi Møss. (2013). The Pharmacokinetics Of Turoctocog Alfa Are Consistent Over Different Concentrations and Production Lots. Blood. 122(21). 4783–4783. 1 indexed citations
8.
Viuff, Dorthe, T W Barrowcliffe, Trine Saugstrup, Mirella Ezban, & David Lillicrap. (2011). International comparative field study of N8 evaluating factor VIII assay performance. Haemophilia. 17(4). 695–702. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026